cognitive cybersecurity intelligence

News and Analysis

Search

Semaglutide and very-low calorie diet combo shows superior results in managing type 2 diabetes

A study by the University of Nottingham found a combination of a very low-calorie diet (VLCD) and diabetes medication Semaglutide was effective at reducing body weight and regulating blood glucose levels in patients with type 2 diabetes. The combined treatment improved pancreatic function and reduced insulin resistance more than the medication alone. Further long-term research is needed to understand the combination treatment’s impact on diabetes and obesity management.

Source: www.news-medical.net –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts